UBS AM’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Other funds holding ORMP
GIA
BCM
UBS AM's ORMP Position: Q3 2026 in Review
UBS AM opened a new position in Oramed Pharmaceuticals (ORMP) in Q3 2026: 150 shares worth $701. The stake represents ﹤0.01% of the portfolio and ranks #4160 among its holdings.
79 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.
- UBS AM held 150 shares of Oramed Pharmaceuticals worth $701 as of Q3 2026.
- Oramed Pharmaceuticals was a new UBS AM position in Q3 2026.
- Oramed Pharmaceuticals made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4160 holding.
- 79 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.